GoodRx and Novo Nordisk: A Shot in the Arm?

GoodRx stock jumps again after Novo Nordisk deal! Discover how their partnership slashes prices on Wegovy and Ozempic, sending shares soaring. Is this a turning point for the volatile stock, or just another bump in a bumpy tech sector? Find out how this deal could impact your portfolio. Hosted on Acast. See acast.com/privacy for more information.